HomeCompareOPALW vs JNJ

OPALW vs JNJ: Dividend Comparison 2026

OPALW yields 136.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OPALW wins by $845020666226204.25M in total portfolio value
10 years
OPALW
OPALW
● Live price
136.99%
Share price
$1.46
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$845020666226204.25M
Annual income
$843,837,299,377,741,400,000.00
Full OPALW calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OPALW vs JNJ

📍 OPALW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPALWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPALW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPALW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPALW
Annual income on $10K today (after 15% tax)
$11,643.84/yr
After 10yr DRIP, annual income (after tax)
$717,261,704,471,080,200,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OPALW beats the other by $717,261,704,471,080,200,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPALW + JNJ for your $10,000?

OPALW: 50%JNJ: 50%
100% JNJ50/50100% OPALW
Portfolio after 10yr
$422510333113102.13M
Annual income
$421,918,649,688,870,700,000.00/yr
Blended yield
99.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OPALW
No analyst data
Altman Z
1.1
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPALW buys
0
JNJ buys
0
No recent congressional trades found for OPALW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPALWJNJ
Forward yield136.99%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$845020666226204.25M$20.0K
Annual income after 10y$843,837,299,377,741,400,000.00$827.78
Total dividends collected$844943059678164.63M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OPALW vs JNJ ($10,000, DRIP)

YearOPALW PortfolioOPALW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$38,097$27,397.26$10,676$355.77+$27.4KOPALW
2$235,859$195,095.43$11,407$389.39+$224.5KOPALW
3$2,510,001$2,257,630.92$12,198$426.53+$2.50MOPALW
4$47,593,276$44,907,575.80$13,056$467.62+$47.58MOPALW
5$1,642,538,294$1,591,613,488.68$13,987$513.12+$1642.52MOPALW
6$104,429,919,545$102,672,403,569.82$14,998$563.56+$104429.90MOPALW
7$12,313,132,201,971$12,201,392,188,057.64$16,098$619.52+$12313132.19MOPALW
8$2,702,227,071,381,351$2,689,052,019,925,242.00$17,295$681.69+$2702227071.36MOPALW
9$1,105,950,325,666,084,200$1,103,058,942,699,706,100.00$18,599$750.82+$1105950325666.07MOPALW
10$845,020,666,226,204,200,000$843,837,299,377,741,400,000.00$20,022$827.78+$845020666226204.25MOPALW

OPALW vs JNJ: Complete Analysis 2026

OPALWStock

OPALW is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in OPALW shares.

Full OPALW Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OPALW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPALW vs SCHDOPALW vs JEPIOPALW vs OOPALW vs KOOPALW vs MAINOPALW vs ABBVOPALW vs MRKOPALW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.